Rephonic
Artwork for Decera Clinical Education Oncology Podcast

Decera Clinical Education Oncology Podcast

Decera Clinical Education
Chronic Lymphocytic Leukemia
BTK Inhibitors
Non-Small Cell Lung Cancer
Mantle Cell Lymphoma
Her3-Targeted Therapy
CAR T-Cell Therapy
Clinical Trials
Triangle Study
SHINE Trial
Pyrtobrutinib
NCCN Guidelines
ASCO Annual Meeting
Acute Myelogenous Leukemia
AML Treatment Regimens
Small Lymphocytic Lymphoma
Gold Standard Therapy
Myelofibrosis
Palliative Care
Oral Sirds
Targeted Therapy

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

PublishesDailyEpisodes236Founded6 years ago
Number of ListenersCategories
EducationHealth & FitnessCoursesMedicine

Listen to this Podcast

Artwork for Decera Clinical Education Oncology Podcast

Latest Episodes

In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including:

• Classifying HER2 expression in MBC today (HER2 negative/ultralow/low/positive) and why this... more

YouTube

Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and Kathleen Boyle, DScPAS, PA-C, about familial cancer syndromes associated with colorectal cancer an... more

Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC, AOCNP, about when to conduct germline and somatic genetic testing in patients with prostat... more

In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the latest results presented at ASCO ... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Aditya Bardia
Medical oncologist at UCLA
Geffen School of Medicine at UCLA
Episode: Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC
Ruta Rao
Breast medical oncologist
Rush University Medical Center
Episode: Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC
Ann Marie Siney
Board certified adult nurse practitioner, UCLA Health
UCLA Health
Episode: Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Kathleen Boyle
Physician assistant, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Brenda Martone
Nurse practitioner
Northwestern Medicine, Lurie Comprehensive Cancer Center
Episode: Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer
Sara Traverso
Physician assistant
Northwestern Medicine, Lurie Comprehensive Cancer Center
Episode: Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer
Sam Chang
From Vanderbilt University Medical Center
Vanderbilt University Medical Center
Episode: Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026
Matt Galsky
From Icahn School of Medicine at Mount Sinai
Mount Sinai Tisch Cancer Institute
Episode: Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026
Dr. Julia Ziegengeist
Pharmacist from Atrium Health
Atrium Health
Episode: Myth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimization

Host

Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#12
Sweden/Education/Courses
Apple Podcasts
#92
Japan/Education/Courses
Apple Podcasts
#114
Austria/Education/Courses
Apple Podcasts
#123
Argentina/Education/Courses
Apple Podcasts
#127
New Zealand/Education/Courses
Apple Podcasts
#132
India/Education/Courses
Apple Podcasts
#133
Singapore/Education/Courses
Apple Podcasts
#158
South Korea/Education/Courses
Apple Podcasts
#176
Netherlands/Education/Courses
Apple Podcasts
#185
Norway/Education/Courses
Apple Podcasts
#186
Belgium/Education/Courses
Apple Podcasts
#228
Denmark/Education/Courses
Apple Podcasts
#230
Sweden/Education

Talking Points

Recent interactions between the hosts and their guests.

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Q: What are the essential biomarkers to test for colorectal cancer, and how do they influence treatment decisions?
Key biomarkers include MSI/MMR, KRAS, BRAF, HER2, and emerging targets like RET and NTRK; their status guides immunotherapy use, EGFR targeting, and eligibility for clinical trials, shaping decisions from early to metastatic disease.
Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Q: Ann Marie, how do you talk to patients about biomarker testing and clarify germline versus somatic testing?
We explain the difference clearly, stressing that germline testing looks for inherited risk shared with family, while somatic testing is tumor-specific and guides treatment decisions; we emphasize the potential impact on family screening and personalized therapy.
Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC
Q: Any final thoughts related to this topic before we move on?
The speakers emphasize a need for careful selection of ADCs based on HER2 expression, consider heterogeneity across tumor samples, and use patient counseling and multidisciplinary support to optimize treatment adherence and manage side effects.
From ASH 2025 to the Clinic: Global Perspectives on Evolving BTK Therapies in Relapsed/Refractory CLL
Q: What were the most impactful BTK inhibitor data presented at ASH 2025?
Pertibutinib showed favorable tolerability in relapse-refractory patients with a safety profile comparable to ibrutinib, while non-covalent BTK inhibitors and degraders demonstrated promising efficacy and safety signals that may alter sequencing and frontline choices in select patients.
Expert Highlights From the 2025 World Conference on Lung Cancer
Q: Dr. Peters, can you tell us about recent advances in non-small cell lung cancer?
Dr. Peters discusses advancements in targeted therapies for non-small cell lung cancer, emphasizing the importance of precision oncology and the development of effective treatments for previously 'undruggable' mutations such as KRAS and HER2.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This program delivers practical, clinically focused insights on cancer care, covering a broad spectrum of solid tumors and hematologic malignancies. Recent episodes spotlight advanced practice professionals and biomarker testing, global perspectives on evolving therapies like BTK inhibitors in hematologic diseases, and data-driven discussions on targeted therapies, immunotherapies, and novel treatment sequencing. Notably, the show frequently features physician-scientists and clinicians from major cancer centers, highlighting real-world challenges such as access disparities, testing turnaround times, and patient education. The format tends to combine data from major conferences with pragmatic takeaways for behind-the-chair practice, making i... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Two Onc Docs
2. NEJM This Week
3. Global News Podcast
4. JAMA Editors' Summary
5. Oncology Brothers: Practice-Changing Cancer Discussions

How many episodes of this podcast are there?

this podcast launched 6 years ago and published 236 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Aditya Bardia
2. Ruta Rao
3. Ann Marie Siney
4. Kathleen Boyle
5. Brenda Martone
6. Sara Traverso
7. Sam Chang
8. Matt Galsky

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days